A new study suggests that medications that have transformed the treatment of obesity may also help people drink less alcohol.

Here is a list of our partners and here's how we make money. How much do credit card processing fees cost? Types of credit card processing fee structures How to calculate your credit card fees How ...

Prepaid debit cards allow you to make purchases with a card from a preloaded balance that's not necessarily attached to a bank account. They can be useful tools for managing your own or someone ...

While it may seem strange that politics could impact the price of popular weight loss drugs, it is a definite possibility.

A rising number of people have accepted GLP-1s as a way to treat obesity, which affects more than 100 million Americans. © 2024 Fortune Media IP Limited. All Rights ...

Copyright 2025 The Associated Press. All Rights Reserved. A new poll from The Associated Press-NORC Center for Public Affairs Research looks at what U.S. adults think ...

It earns 3% cash back at specific merchants and 2% back on everything else — but only if you use the card with Apple Pay. It's not a game-changer, but the card does offer some intriguing ...

Weight loss drugs are popular—but often expensive. Luckily, there are a few ways to lower the costs, which we explore in this article.

It was dubbed the "King Kong" of weight loss drugs by US expert Dr Julio Rosenstock after its effect size emerged , compared to the "gorilla" of Wegovy. The two biggest selling GLP-1 drugs are ...

In recent years, the pharmaceutical industry has undergone significant changes in the focus of its innovation, research and development efforts. Historically, oncology and immunology were the ...

“The phase 2b QUALITY study is the first human study to demonstrate that older patients who are overweight or have obesity and receiving only a Wegovy (semaglutide) GLP-1 RA are at higher risk ...

About 140,400 obese patients in Massachusetts were prescribed medications like Wegovy and Zepbound in 2024, a 255 percent increase from 2023, according to a Globe analysis of insurance claims data.